308 related articles for article (PubMed ID: 20592279)
1. IL-17 immunity in human type 1 diabetes.
Honkanen J; Nieminen JK; Gao R; Luopajarvi K; Salo HM; Ilonen J; Knip M; Otonkoski T; Vaarala O
J Immunol; 2010 Aug; 185(3):1959-67. PubMed ID: 20592279
[TBL] [Abstract][Full Text] [Related]
2. IL-10 suppresses Th17 cells and promotes regulatory T cells in the CD4+ T cell population of rheumatoid arthritis patients.
Heo YJ; Joo YB; Oh HJ; Park MK; Heo YM; Cho ML; Kwok SK; Ju JH; Park KS; Cho SG; Park SH; Kim HY; Min JK
Immunol Lett; 2010 Jan; 127(2):150-6. PubMed ID: 19895848
[TBL] [Abstract][Full Text] [Related]
3. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
[TBL] [Abstract][Full Text] [Related]
4. Th17 transcription factor RORC2 is inversely correlated with FOXP3 expression in the joints of children with juvenile idiopathic arthritis.
Olivito B; Simonini G; Ciullini S; Moriondo M; Betti L; Gambineri E; Cantarini L; De Martino M; Azzari C; Cimaz R
J Rheumatol; 2009 Sep; 36(9):2017-24. PubMed ID: 19648312
[TBL] [Abstract][Full Text] [Related]
5. Cutting edge: Increased IL-17-secreting T cells in children with new-onset type 1 diabetes.
Marwaha AK; Crome SQ; Panagiotopoulos C; Berg KB; Qin H; Ouyang Q; Xu L; Priatel JJ; Levings MK; Tan R
J Immunol; 2010 Oct; 185(7):3814-8. PubMed ID: 20810982
[TBL] [Abstract][Full Text] [Related]
6. Tc17 CD8+ T cells potentiate Th1-mediated autoimmune diabetes in a mouse model.
Saxena A; Desbois S; Carrié N; Lawand M; Mars LT; Liblau RS
J Immunol; 2012 Sep; 189(6):3140-9. PubMed ID: 22904307
[TBL] [Abstract][Full Text] [Related]
7. The role of retinoic acid-related orphan receptor variant 2 and IL-17 in the development and function of human CD4+ T cells.
Crome SQ; Wang AY; Kang CY; Levings MK
Eur J Immunol; 2009 Jun; 39(6):1480-93. PubMed ID: 19449310
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo IL-1 receptor type I expression in human CD4+ T cells identifies an early intermediate in the differentiation of Th17 from FOXP3+ naive regulatory T cells.
Raffin C; Raimbaud I; Valmori D; Ayyoub M
J Immunol; 2011 Nov; 187(10):5196-202. PubMed ID: 21998454
[TBL] [Abstract][Full Text] [Related]
9. IL-21 regulates Th17 cells in rheumatoid arthritis.
Niu X; He D; Zhang X; Yue T; Li N; Zhang JZ; Dong C; Chen G
Hum Immunol; 2010 Apr; 71(4):334-41. PubMed ID: 20079789
[TBL] [Abstract][Full Text] [Related]
10. Neonatal formula feeding leads to immunological alterations in an animal model of type 1 diabetes.
Caicedo RA; Li N; Des Robert C; Scumpia PO; Hubsher CP; Wasserfall CH; Schatz DA; Atkinson MA; Neu J
Pediatr Res; 2008 Mar; 63(3):303-7. PubMed ID: 18091354
[TBL] [Abstract][Full Text] [Related]
11. High T-helper-1 cytokines but low T-helper-3 cytokines, inflammatory cytokines and chemokines in children with high risk of developing type 1 diabetes.
Stechova K; Bohmova K; Vrabelova Z; Sepa A; Stadlerova G; Zacharovova K; Faresjö M
Diabetes Metab Res Rev; 2007 Sep; 23(6):462-71. PubMed ID: 17315139
[TBL] [Abstract][Full Text] [Related]
12. Th17 cells in type 1 diabetes.
Shao S; He F; Yang Y; Yuan G; Zhang M; Yu X
Cell Immunol; 2012 Nov; 280(1):16-21. PubMed ID: 23246831
[TBL] [Abstract][Full Text] [Related]
13. IFN-beta inhibits human Th17 cell differentiation.
Ramgolam VS; Sha Y; Jin J; Zhang X; Markovic-Plese S
J Immunol; 2009 Oct; 183(8):5418-27. PubMed ID: 19783688
[TBL] [Abstract][Full Text] [Related]
14. Diverse foxp3 expression in children with type 1 diabetes and celiac disease.
Kivling A; Nilsson L; Fälth-Magnusson K; Söllvander S; Johanson C; Faresjö M
Ann N Y Acad Sci; 2008 Dec; 1150():273-7. PubMed ID: 19120312
[TBL] [Abstract][Full Text] [Related]
15. RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F.
Leppkes M; Becker C; Ivanov II; Hirth S; Wirtz S; Neufert C; Pouly S; Murphy AJ; Valenzuela DM; Yancopoulos GD; Becher B; Littman DR; Neurath MF
Gastroenterology; 2009 Jan; 136(1):257-67. PubMed ID: 18992745
[TBL] [Abstract][Full Text] [Related]
16. Poor in vitro induction of FOXP3 and ICOS in type 1 cytokine environment activated T-cells from children with type 1 diabetes.
Honkanen J; Skarsvik S; Knip M; Vaarala O
Diabetes Metab Res Rev; 2008; 24(8):635-41. PubMed ID: 18973208
[TBL] [Abstract][Full Text] [Related]
17. Restricted microbiota and absence of cognate TCR antigen leads to an unbalanced generation of Th17 cells.
Lochner M; Bérard M; Sawa S; Hauer S; Gaboriau-Routhiau V; Fernandez TD; Snel J; Bousso P; Cerf-Bensussan N; Eberl G
J Immunol; 2011 Feb; 186(3):1531-7. PubMed ID: 21178008
[TBL] [Abstract][Full Text] [Related]
18. IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis.
Rothe H; Hausmann A; Casteels K; Okamura H; Kurimoto M; Burkart V; Mathieu C; Kolb H
J Immunol; 1999 Aug; 163(3):1230-6. PubMed ID: 10415018
[TBL] [Abstract][Full Text] [Related]
19. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.
Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M
J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306
[TBL] [Abstract][Full Text] [Related]
20. The role of the novel Th17 cytokine IL-26 in intestinal inflammation.
Dambacher J; Beigel F; Zitzmann K; De Toni EN; Göke B; Diepolder HM; Auernhammer CJ; Brand S
Gut; 2009 Sep; 58(9):1207-17. PubMed ID: 18483078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
